重组人KLRB1(CD161)(杀伤细胞凝集素样受体B1)

特别提示：包括重组人KLRB1(CD161)(杀伤细胞凝集素样受体B1)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人KLRB1(CD161)(杀伤细胞凝集素样受体B1)
英文名称：Recombinant Human Killer cell lectin-like receptor subfamily B member 1
产品货号：JN1365
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Gln67-Ser225在C端带有Fc标签。

KLRB1/CD161质量控制：＞95%(还原性SDS-PAGE)

KLRB1/CD161制剂：冻干品

KLRB1/CD161保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

KLRB1/CD161复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于KLRB1/CD161：
Killer cell lectin-like receptor subfamily B, member 1(KLRB1) is a single-pass type II membrane protein which contains 1 C-type lectin domain. KLRB1 plays an inhibitory role on natural killer (NK) cells cytotoxicity. Activation results in specific acid sphingomyelinase/SMPD1 stimulation with subsequent marked elevation of intracellular ceramide. Activation also leads to AKT1/PKB and RPS6KA1/RSK1 kinases stimulation as well as markedly enhanced T-cell proliferation induced by anti-CD3. It acts as a lectin that binds to the terminal carbohydrate Gal-alpha(1,3)Gal epitope as well as to the N-acetyllactosamine epitope. Binds also to CLEC2D/LLT1 as a ligand and inhibits NK cell-mediated cytotoxicity as well as interferon-gamma secretion in target cells.

我公司销售的重组人KLRB1(CD161)(杀伤细胞凝集素样受体B1)，rKLRB1，重组人KLRB1，重组人CD161，rhKLRB1，重组杀伤细胞凝集素样受体B1，重组人杀伤细胞凝集素样受体B1，重组KLRB1，rCD161，rhCD161，重组CD161质量上佳，价格普惠，欢迎广大新老客户踊跃订购。